Navigation Links
Baylor Heart and Vascular Hospital Announces First Patient Procedure in the United States to Treat Atrial Fibrillation Using New Catheter for Cryoablation Technology
Date:5/2/2011

DALLAS, May 2, 2011 /PRNewswire-USNewswire/ -- Baylor Jack and Jane Hamilton Heart and Vascular Hospital today announced the first patient procedure in the U.S. using the Achieve™ Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess pulmonary vein isolation when treating paroxysmal atrial fibrillation (PAF). Atrial fibrillation is the most common and one of the most undertreated heart rhythm disorders. The procedure was performed last week by an electrophysiologist on the medical staff at Baylor Heart and Vascular Hospital in Dallas.

The new catheter technology is approved by the U.S. Food and Drug Administration for use with Medtronic's Arctic Front® Cardiac CryoAblation Catheter System to provide a more straightforward treatment approach. When used in conjunction with Arctic Front, the Achieve Mapping Catheter combines pulmonary vein diagnostic and ablation capabilities in a single system. The Achieve Mapping Catheter is deployed through the Arctic Front guide wire lumen enabling the Arctic Front procedure to be performed using a single transseptal puncture with minimal catheter exchanges, enabling physicians to map electrical conduction between the left atrium and pulmonary veins in order to assess pulmonary vein potentials before, during and after cryoablation.

"In many cases, this new mapping catheter will allow real-time assessment for PV isolation and provide valuable information regarding time-to-effect during the cryoablation procedure," said Dr. Robert Kowal, M.D., Ph. D., an electrophysiologist on the medical staff at BHVH. "The procedure can be completed more efficiently by incorporating this new technology."

The Arctic Front Cardiac CryoAblation Catheter, approved by the FDA in December 2010, is the first and only cryoballoon in the United States indicated for the treatment of PAF. Baylor Heart and Vascular Hospital was the first in North Texas to offer the Arctic Front CryoAblation Catheter and was a major participant in the STOP-AF trial which demonstrated its effectiveness.  The cryoablation treatment involves a minimally-invasive procedure that creates circumferential lesions around the pulmonary vein (the source of erratic electrical signals that cause atrial fibrillation) and blocks the conduction of atrial fibrillation in cardiac tissue through the use of a coolant.

ABOUT BAYLOR HAMILTON HEART AND VASCULAR HOSPITAL:

Baylor Jack and Jane Hamilton Heart and Vascular Hospital (Baylor Hamilton) was the first hospital in North Texas dedicated solely to the care and treatment of patients with cardiovascular disease. The 64-bed Baylor Hamilton was recognized in 2009 and again in 2010 for having the nation's lowest readmission rate for heart failure patients for the second consecutive year and continues to receive a five star rating by HealthGrades, a leading independent health care rating organization. At BHVH, more than 600 procedures to treat atrial fibrillation are performed annually.  For more information about Baylor Hamilton Heart and Vascular Hospital, visit BaylorHeartHospital.com.

Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor University Medical Center at Dallas or Baylor Health Care System.


'/>"/>
SOURCE Baylor Jack and Jane Hamilton Heart and Vascular Hospital
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baylor Adds Naviscan PEM Technology to Womens Imaging Center
2. Baylor Health Care System Registers its Commitment to Achieve Meaningful Use of the Electronic Health Record
3. Baylor Hamilton Heart Hospital Implants First MRI-Safe Pacemaker in North Texas
4. Many Heart Attack Patients Dont Get Best Emergency Treatment
5. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
8. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
9. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
10. Its Only Heartburn...or is it? Chronic Heartburn a Risk Factor for Precursor to Esophageal Cancer
11. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017  Ablation is the ... a wide range of purposes, from cancerous or ... conducting cardiac tissue in atrial fibrillation and others. ... pushing the researchers to innovate and improvise existing ... The ablation device global market is expected to ...
(Date:3/22/2017)... 2017  Applied BioMath ( www.appliedbiomath.com ), the ... and development, today announced the latest line-up of ... is a day full of presentations, posters, and ... community. The focus is to learn about how ... drug research and development. The event ...
(Date:3/22/2017)... A new independent study demonstrates that ... ultraviolet-C (UV-C) disinfection solution of choice for combating ... Published in the March issue of the ... peer-reviewed study of UV-C disinfection systems detailed the ... and Rochester General Hospital. According to the study, ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... 2017 , ... An intensive search of the medical literature has revealed no ... PhD. He says investigating this possibility, is important because Miami-Dade in 2016 ... infections with HIV. , His findings appear on Analizir.com. . Dr. ...
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic Imaging, LLC, an ... and operational excellence in oncology clinical trials, proudly announces today that it has ... non-small cell lung cancer and small cell lung cancer. , Throughout this trial, ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... services to regional families and business owners, is joining the Teen Recovery Solutions ... in the area. , A growing number of Oklahoma teens and adolescents face ...
(Date:3/22/2017)... ... 22, 2017 , ... College basketball surges to its peak during the March ... that is, recruiting people to be foster parents. Through a televised spot, Coach Self ... foster care due to abuse, neglect and other family challenges. People who respond to ...
(Date:3/22/2017)... ... 2017 , ... Nearly a decade after it was first recommended that men ... screening continues to stir controversy. The US Preventative Services Task Force (USPSTF) issued a ... benefits. Now, news from a study published in JAMA Oncology suggests that ...
Breaking Medicine News(10 mins):